Pegaspargase [clinicaltrials_resource:0e1e1692ec5237ef46e2d71f78059629]
clinicaltrials:NCT00002590clinicaltrials:NCT00002744clinicaltrials:NCT00002766Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia [clinicaltrials:NCT00002785]clinicaltrials:NCT00002812clinicaltrials:NCT00002816Hormone Therapy Plus Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia [clinicaltrials:NCT00003437]clinicaltrials:NCT00005585clinicaltrials:NCT00005596clinicaltrials:NCT00005945Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [clinicaltrials:NCT00016302]clinicaltrials:NCT00022126Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia [clinicaltrials:NCT00022737]Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia [clinicaltrials:NCT00049569]clinicaltrials:NCT00075725clinicaltrials:NCT00096135clinicaltrials:NCT00098839Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [clinicaltrials:NCT00103285]clinicaltrials:NCT00137111Intensified Post Remission Therapy Containing PEG-Asparaginase [clinicaltrials:NCT00184041]clinicaltrials:NCT00186875Total Therapy Study XIV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia [clinicaltrials:NCT00187005]A Study of Children With Refractory or Relapsed ALL [clinicaltrials:NCT00187083]Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses [clinicaltrials:NCT00192673]Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia [clinicaltrials:NCT00343369]Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia [clinicaltrials:NCT00381680]clinicaltrials:NCT00400946Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma [clinicaltrials:NCT00408005]clinicaltrials:NCT00439296Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL) [clinicaltrials:NCT00440726]clinicaltrials:NCT00476190clinicaltrials:NCT00537030clinicaltrials:NCT00549848Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia [clinicaltrials:NCT00550992]Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [clinicaltrials:NCT00557193]Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [clinicaltrials:NCT00558519]Calaspargase Pegol or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia [clinicaltrials:NCT00671034]Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [clinicaltrials:NCT00720109]clinicaltrials:NCT00819351clinicaltrials:NCT00837200
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Pegaspargase [clinicaltrials_resource:0e1e1692ec5237ef46e2d71f78059629]
Bio2RDF identifier
0e1e1692ec5237ef46e2d71f78059629
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0e1e1692ec5237ef46e2d71f78059629
identifier
clinicaltrials_resource:0e1e1692ec5237ef46e2d71f78059629
title
Pegaspargase
@en
type
label
Pegaspargase [clinicaltrials_resource:0e1e1692ec5237ef46e2d71f78059629]
@en